For Immediate Release: May 06, 2020

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

Today, the FDA issued an immediately in effect guidance Notifying the Center for Devices and Radiological Health of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the Federal Food, Drug, and Cosmetic Act During the COVID-19 Public Health Emergency. This guidance is intended to assist manufacturers in providing FDA timely, informative notifications about changes in the production of certain medical

Read More At Article Source | Article Attribution